HIV-1 infection and antibodies to Plasmodium alciparum in adults

Journal of Infectious Diseases

Volumn 210, Issue 9, 2014, Pages 1407-1414

  Hasang, Wina ^a,b   Dembo, Edson G ^c,f   Wijesinghe, Rushika ^a,g   Molyneux, Malcolm E ^c,d   Kublin, James G ^e   Rogerson, Stephen ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c UNIVERSITY OF MALAWI   (Malawi)

^d LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^e Fred Hutchinson Cancer Research Center   (United States)

^f UNIVERSITY OF CAMERINO   (Italy)

^g NONE   (Australia)

Author keywords

Antibody; HIV; IgG; Malaria; Merozoite antigens; Phagocytosis; Plasmodium falciparum; Variant surface antigens

Indexed keywords

ANTIGEN; APICAL MEMBRANE ANTIGEN 1; IMMUNOGLOBULIN G; MALARIA ANTIBODY; MEROZOITE SURFACE PROTEIN 2; PROTOZOAL PROTEIN; PROTOZOON ANTIBODY; UNCLASSIFIED DRUG; VARIANT SURFACE ANTIGEN; PARASITE ANTIGEN;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE DEFICIENCY; INFECTION RISK; INFECTION SENSITIVITY; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; MEROZOITE; MIXED INFECTION; OPSONIZATION; PARASITEMIA; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; VIRUS LOAD; ADOLESCENT; CASE CONTROL STUDY; CD4 LYMPHOCYTE COUNT; COMPLICATION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MALARIA FALCIPARUM; MIDDLE AGED; PARASITOLOGY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; COINFECTION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOGLOBULIN G; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; PLASMODIUM FALCIPARUM; YOUNG ADULT;

EID: 84922031830     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu262     Document Type: Article

References (46)

1. World Health Organization. Malaria and HIV Interactions and Their Implications for Public Health Policy. http://www.who.int/hiv/pub/ prev-care/malariahiv.pdf. Accessed 20 December 2013.
2. González R, Ataide R, Naniche D, et al. HIV and malaria interactions: where do we stand? Expert Rev Anti Infect Ther 2012; 10:153-65.
3. Kamya MR, Byakika-Kibwika P, Gasasira AF, et al. The effect of HIV on malaria in the context of the current standard of care for HIV-infected populations in Africa. Future Virol 2012; 7:699-708.
4. Birku Y, Mekonnen E, Bjorkman A, Wolday D. Delayed clearance of Plasmodium falciparum in patients with human immunodeficiency virus co-infection treated with artemisinin. Ethiop Med J 2002; 40 (suppl 1):17-26.
5. Chalwe V, Van geertruyden J-P, Mukwamataba D, et al. Increased risk for severe malaria in HIV-1-infected adults, Zambia. Emerg Infect Dis 2009; 15:749.
6. Kamya MR, Gasasira AF, Yeka A, et al. Effect of HIV-1 Infection on antimalarial treatment outcomes in Uganda: a population-based study. J Infect Dis 2006; 193:9-15.
7. Van Geertruyden J-P, Van Eijk E, Yosaatmadja F, et al. The relationship of Plasmodium falciparum humeral immunity with HIV-1 immunosuppression and treatment efficacy in Zambia. Malar J 2009; 8:258.
8. van Eijk AM, Ayisi JG, ter Kuile FO, et al. Human immunodeficiency virus seropositivity and malaria as risk factors for third-trimester anemia in asymptomatic pregnant women in western Kenya. Am J Trop Med Hyg 2001; 65:623-30.
9. Ataíde R, Mwapasa V, Molyneux ME, Meshnick SR, Rogerson SJ. Antibodies that induce phagocytosis of malaria infected erythrocytes: effect of HIV infection and correlation with clinical outcomes. PLoS ONE 2011; 6:e22491.
10. Jaworowski A, Fernandes LA, Yosaatmadja F, et al. Relationship between human immunode fi ciency virus type 1 coinfection, anemia, and levels and function of antibodies to variant surface antigens in pregnancy-associated malaria. Clin Vaccine Immunol 2009; 16:312-9.
11. Mount AM, Mwapasa V, Elliott SR, et al. Impairment of humoral immunity to Plasmodium falciparum malaria in pregnancy by HIV infection. Lancet 2004; 363:1860-7.
12. Briand V, Badaut C, Cot M. Placental malaria, maternal HIV infection and infant morbidity. Ann Trop Paediatr 2009; 29:71-83.
13. ter Kuile FO, Parise ME, Verhoeff FH, et al. The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-Saharan Africa. Am J Trop Med Hyg 2004; 71:41-54.
14. Ticconi C, Mapfumo M, Dorrucci M, et al. Effect of maternal HIV and malaria infection on pregnancy and perinatal outcome in Zimbabwe. J Acquir Immune Defic Syndr 2003; 34:289-94.
15. Schwartz L, Brown GV, Genton B, Moorthy VS. A review of malaria vaccine clinical projects based on the WHO rainbow table. Malar J 2012; 11:1475-2875.
16. Newbold CI, Pinches R, Roberts DJ, Marsh K. Plasmodium falciparum: the human agglutinating antibody response to the infected red cell surface is predominantly variant specific. Exp Parasitol 1992; 75:281-92.
17. Duffy PE, Fried M. Adherence of Plasmodium falciparum to chrondroitin sulfate A in the human placenta. Science 1996; 272:1502-4.
18. Beeson JG, Rogerson SJ, Cooke BM, et al. Adhesion of Plasmodium fal-ciparum- infected erythrocytes to hyaluronic acid in placental malaria. Nat J Nat Med 2000; 6:86-90.
19. Kublin JG, Patnaik P, Jere CS, et al. Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study. Lancet 2005; 365:233-40.
20. Patnaik P, Jere CS, Miller WC, et al. Effects of HIV-1 serostatus, HIV-1 RNA Concentration, and CD4 cell count on the incidence of malaria infection in a cohort of adults in rural Malawi. J Infect Dis 2005; 192:984-91.
21. Rowe JA, Moulds JM, Newbold CI, Miller LH. P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and com-plement- receptor 1. Nat J 1997; 388:292-5.
22. Ataíde R, Hasang W, Wilson DW, et al. Using an improved phagocytosis assay to evaluate the effect of HIV on specific antibodies to pregnancyassociated Malaria. PLoS ONE 2010; 5:e10807.
23. Cohen C, Karstaedt A, Frean J, et al. Increased prevalence of severe malaria in HIV-infected adults in South Africa. Clin Infect Dis 2005; 41:1631-7.
24. Campbell JD, Moore D, Degerman R, et al. HIV-infected Ugandan adults taking antiretroviral therapy with CD4 counts >200 cells/μL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrhea. Clin Infect Dis 2012; 54:1204-11.
25. Mermin J, Ekwaru JP, Liechty CA, et al. Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study. Lancet 2006; 367:1256-61.
26. Achan J, Kakuru A, Ikilezi G, et al. Antiretroviral agents and prevention of malaria in HIV-infected Ugandan children. N Engl J Med 2012; 367:2110-8.
27. Keen J, Serghides L, Ayi K, et al. HIV impairs opsonic phagocytic clearance of pregnancy-associated malaria parasites. PLoS Med 2007; 4:e181.
28. Ludlow LE, Zhou J, Tippett E, et al. HIV-1 inhibits phagocytosis and inflammatory cytokine responses of human monocyte-derived macrophages to P. falciparum infected erythrocytes. PLoS ONE 2012; 7:21.
29. Biggs BA, Anders RF, Dillon HE, et al. Adherence of infected erythrocytes to venular endothelium selects for antigenic variants of Plasmodium falciparum. J Immunol 1992; 149:2047-54.
30. Smith JD, Chitnis CE, Craig AG, et al. Switches in expression of Plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes. Cell 1995; 82:101-10.
31. Rowe A, Obeiro J, Newbold CI, Marsh K. Plasmodium falciparum rosetting is associated with malaria severity in Kenya. Infect Immun 1995; 63:2323-6.
32. Carlson J, Helmby H, Hill AV, Brewster D, Greenwood BM, Wahlgren M. Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies. Lancet 1990; 336:1457-60.
33. Janes JH, Wang CP, Levin-Edens E, et al. Investigating the host binding SigNat J on the Plasmodium falciparum PfEMP1 protein family. PLoS Pathog 2011; 7:e1002032.
34. Robinson BA, Welch TL, Smith JD. Widespread functional specialization of Plasmodium falciparum erythrocyte membrane protein 1 family members to bind CD36 analysed across a parasite genome. Mol Microbiol 2003; 47:1265-78.
35. McGilvray ID, Serghides L, Kapus A, Rotstein OD, Kain KC. Nonopsonic monocyte/macrophage phagocytosis of Plasmodium falciparumparasitized erythrocytes: a role for CD36 in malarial clearance. Blood 2000; 96:3231-40.
36. Salanti A, Dahlback M, Turner L, et al. Evidence for the involvement of VAR2CSA in pregnancy-associated malaria. J Exp Med 2004; 200: 1197-203.
37. Muema D, Ndungu F, Kinyanjui S, Berkley J. Effect of HIV infection on the acute antibody response to malaria antigens in children: an observational study. Malar J 2011; 10:55.
38. Moncunill G, Mayor A, Jimenez A, et al. High antibody responses against Plasmodium falciparum in immigrants after extended periods of interrupted exposure to malaria. PLoS One 2013; 8:e73624.
39. Fowkes FJ, McGready R, Cross NJ, et al. New insights into acquisition, boosting, and longevity of immunity to malaria in pregnant women. J Infect Dis 2012; 206:1612-21.
40. Feng G, Aitken E, Yosaatmadja F, et al. Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes are associated with protection from treatment failure and the development of anemia in pregnancy. J Infect Dis 2009; 200:299-306.
41. Groux H, Gysin J. Opsonization as an effector mechanism in human protection against asexual blood stages of Plasmodium falciparum: functional role of IgG subclasses. Res Immunol 1990; 141:529-42.
42. Elliott SR, Brennan AK, Beeson JG, et al. Placental malaria induces var-iant- specific antibodies of the cytophilic subtypes immunoglobulin G1 (IgG1) and IgG3 that correlate with adhesion inhibitory activity. Infect Immun 2005; 73:5903-7.
43. Cabrera G, Yone C, Tebo AE, et al. Immunoglobulin G isotype responses to variant surface antigens of Plasmodium falciparum in healthy Gabonese adults and children during and after successive malaria attacks. Infect Immun 2004; 72:284-94.
44. Yone CLRP, Kremsner PG, Luty AJF. Immunoglobulin G isotype responses to erythrocyte surface-expressed variant antigens of Plasmodium falciparum predict protection from malaria in African children. Infect Immun 2005; 73:2281-7.
45. Aucouturier P, Couderc LJ, Gouet D, et al. Serum immunoglobulin G subclass dysbalances in the lymphadenopathy syndrome and acquired immune deficiency syndrome. Clin Exp Immunol 1986; 63:234-40.
46. Crum-Cianflone NF, Collins G, Defang G, et al. Immunoglobulin G subclass levels and antibody responses to the 2009 influenza A (H1N1) monovalent vaccine among human immunodeficiency virus (HIV)-infected and HIV-uninfected adults. Clin Exp Immunol 2012; 168:135-41.